5.85
0.01 (0.17%)
| Previous Close | 5.84 |
| Open | 5.84 |
| Volume | 108,297 |
| Avg. Volume (3M) | 1,241,811 |
| Market Cap | 224,476,192 |
| Price / Sales | 0.530 |
| Price / Book | 0.970 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -27.77% |
| Operating Margin (TTM) | -21.79% |
| Diluted EPS (TTM) | -3.06 |
| Quarterly Revenue Growth (YOY) | -9.10% |
| Total Debt/Equity (MRQ) | 108.86% |
| Current Ratio (MRQ) | 4.62 |
| Operating Cash Flow (TTM) | -19.44 M |
| Levered Free Cash Flow (TTM) | -4.77 M |
| Return on Assets (TTM) | -9.95% |
| Return on Equity (TTM) | -43.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Nevro Corp. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Average | -0.63 |
|
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.84% |
| % Held by Institutions | 110.59% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Palo Alto Investors Lp | 31 Dec 2024 | 750,371 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |